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Background:  Delayed left ventricular activation time (LVAT) has recently been associated with enhanced reverse remodeling in patients 
undergoing cardiac resynchronization therapy (CRT) who were not chronically right ventricular (RV) paced. It is unknown if delayed LVAT predicts 
long-term clinical outcomes and whether it has similar predictive value in RV paced vs. non-paced patients.
Methods:  Baseline 12-lead ECGs of consecutive patients (n = 219; 82% male; 67+/-10 years; 69% ischemic etiology; 28% atrial fibrillation) 
undergoing CRT implantation were analyzed. Of these, 68 (31%) were chronically RV paced prior to CRT. Maximum LVAT was measured as QRS-
duration minus right ventricular activation time (time from QRS onset to the first notch). LVAT was assessed masked to clinical outcome. Cox models 
were used to assess the association between LVAT and all-cause mortality or cardiac transplant.
Results:  Over a median follow-up of 56 months 92 patients (42%) died and 10 (5%) underwent cardiac transplant. In the RV paced group 25 
(37%) deaths and 4 (6%) transplants occurred over a median follow-up of 55 months. In the non-RV paced group an independent linear relationship 
between LVAT and outcome (hazard ratio (HR) 0.66 per 50 ms increase in LVAT; 95% confidence interval (CI) 0.45 to 0.96; p=0.03) was observed. 
Patients with delayed LVAT (> 125 ms) had better survival vs. those without delayed values ( 125 ms remained associated with a markedly lower 
risk of death or transplant (HR 0.51; 95% CI 0.30 to 0.86) despite adjustment for age, gender, etiology of LV dysfunction, baseline NYHA class and 
baseline ejection fraction. Despite a similar risk of death or transplant, no significant relationship between LVAT and outcome was observed in the 
RV paced cohort.
Conclusion: A simple ECG measure, prolonged LVAT, independently predicts improved long-term outcome with CRT in non-RV paced patients. 
However, prolonged LVAT was not associated with an altered prognosis in patients chronically RV paced prior to CRT.
